The recruited M2-TAMs inhibit miR-340-5p expression in GBM cells through the TGF-β/High mobility group AT-hook 2 (HMGA2) pathway, assuring a continuous feedback loop and maintaining GBM tumorigenicity. Here, TGFB1 is linked to glioblastoma.